uniQure (QURE) Total Current Liabilities (2015 - 2026)

uniQure's (QURE) quarterly Total Current Liabilities came in at $59.2 million in Q1 2026, up 63.03% year-on-year from $36.3 million in Q1 2025, and down 5.92% quarter-over-quarter from $62.9 million in Q4 2025.

uniQure (QURE) Total Current Liabilities (2015 - 2026) Analysis & Trends

uniQure's Total Current Liabilities history runs 12 years deep, the most recent figure standing at $59.2 million for Q1 2026.

  • On a quarterly basis, Total Current Liabilities rose 63.03% year-over-year to $59.2 million in Q1 2026; TTM through Mar 2026 was $59.2 million, a 63.03% increase from a year earlier, with the FY2025 full-year figure at $62.9 million, up 57.09% from the prior year.
  • Total Current Liabilities retreated to $59.2 million in Q1 2026 per QURE's latest filing, from $62.9 million in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $100.6 million in Q3 2025 and bottomed at $36.3 million in Q1 2025.
  • The 5-year median for Total Current Liabilities is $64.0 million (2022), against an average of $62.7 million.
  • Across the five-year window, Total Current Liabilities jumped 106.51% in 2022 and slumped 49.14% in 2025, its largest moves.
  • Year by year, Total Current Liabilities stood at $75.9 million in 2022, then fell by 2.96% to $73.7 million in 2023, then plunged by 45.64% to $40.1 million in 2024, then surged by 57.09% to $62.9 million in 2025, then retreated by 5.92% to $59.2 million in 2026.
  • Per Business Quant, the three latest QURE Total Current Liabilities figures stand at $59.2 million (Q1 2026), $62.9 million (Q4 2025), and $100.6 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 56.01 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 66.94 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1.81 Bn
4 NuCana 279.75 Bn 279.75 Bn - 6.38 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 3.88 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 5.11 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 1.58 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 289.60 Mn
10 uniQure 2.47 Bn 2.47 Bn 3.34 Mn 59.20 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 59.20 Mn
Dec 31, 2025 62.92 Mn
Sep 30, 2025 100.63 Mn
Jun 30, 2025 40.93 Mn
Mar 31, 2025 36.31 Mn
Dec 31, 2024 40.05 Mn
Sep 30, 2024 71.27 Mn
Jun 30, 2024 80.47 Mn
Mar 31, 2024 63.47 Mn
Dec 31, 2023 73.68 Mn
Sep 30, 2023 68.61 Mn
Jun 30, 2023 68.36 Mn
Mar 31, 2023 66.34 Mn
Dec 31, 2022 75.92 Mn
Sep 30, 2022 63.97 Mn
Jun 30, 2022 48.26 Mn
Mar 31, 2022 44.70 Mn
Dec 31, 2021 36.76 Mn
Sep 30, 2021 41.92 Mn
Jun 30, 2021 46.10 Mn